Interferon-alpha 2 (CJ Corporation)

干扰素-α2(CJ Corporation)

Report date: 2022/01/24 10:09:31

Base Information

Drug NameInterferon-alpha 2 (CJ Corporation)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple MyelomaCarcinoma, Renal CellMelanoma +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHK inno.N Corporation
China Registration ClassN/A

Develop Information

Active CompaniesHK inno.N Corporation
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaCarcinoma, Renal CellMelanoma +[7
Inactive IndicationsN/A

Other Information

ATC CodeL03AB
Related LinksN/A